| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alcohol Drinking | |||||
| 2 | More general conditions related to this trial | ||||
| Drinking Behavior | |||||
| 3 | Interventions listed in this trial | ||||
| topiramate | |||||
| placebo | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Obesity Agents | |||||
| Anticonvulsants | |||||
| Central Nervous System Agents | |||||
| Neuroprotective Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Connecticut Health Center | |||||
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |||||
| National Center for Research Resources (NCRR) | |||||
|
